NO971269L - 2-aryl-substituerte pyridiner - Google Patents
2-aryl-substituerte pyridinerInfo
- Publication number
- NO971269L NO971269L NO971269A NO971269A NO971269L NO 971269 L NO971269 L NO 971269L NO 971269 A NO971269 A NO 971269A NO 971269 A NO971269 A NO 971269A NO 971269 L NO971269 L NO 971269L
- Authority
- NO
- Norway
- Prior art keywords
- aryl
- carbon atoms
- optionally substituted
- substituted pyridines
- stands
- Prior art date
Links
- 150000003222 pyridines Chemical class 0.000 title abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 150000002894 organic compounds Chemical class 0.000 abstract 1
- -1 pyridyl aldehyde Chemical class 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19610932A DE19610932A1 (de) | 1996-03-20 | 1996-03-20 | 2-Aryl-substituierte Pyridine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO971269D0 NO971269D0 (no) | 1997-03-19 |
| NO971269L true NO971269L (no) | 1997-09-22 |
Family
ID=7788843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO971269A NO971269L (no) | 1996-03-20 | 1997-03-19 | 2-aryl-substituerte pyridiner |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US5925645A (fr) |
| EP (1) | EP0796846B1 (fr) |
| JP (1) | JPH09255574A (fr) |
| AR (1) | AR006318A1 (fr) |
| AT (1) | ATE194832T1 (fr) |
| AU (1) | AU1628097A (fr) |
| BG (1) | BG101339A (fr) |
| BR (1) | BR9701348A (fr) |
| CA (1) | CA2200175A1 (fr) |
| CO (1) | CO4520282A1 (fr) |
| CZ (1) | CZ84397A3 (fr) |
| DE (2) | DE19610932A1 (fr) |
| DK (1) | DK0796846T3 (fr) |
| EE (1) | EE9700060A (fr) |
| ES (1) | ES2150157T3 (fr) |
| GR (1) | GR3034546T3 (fr) |
| HR (1) | HRP970105A2 (fr) |
| HU (1) | HUP9700610A1 (fr) |
| ID (1) | ID16292A (fr) |
| IL (1) | IL120468A0 (fr) |
| MY (1) | MY132490A (fr) |
| NO (1) | NO971269L (fr) |
| NZ (1) | NZ314419A (fr) |
| PL (1) | PL319050A1 (fr) |
| PT (1) | PT796846E (fr) |
| SG (1) | SG50805A1 (fr) |
| SK (1) | SK36197A3 (fr) |
| TN (1) | TNSN97048A1 (fr) |
| TR (1) | TR199700213A2 (fr) |
| ZA (1) | ZA972375B (fr) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6268392B1 (en) | 1994-09-13 | 2001-07-31 | G. D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors |
| US6642268B2 (en) | 1994-09-13 | 2003-11-04 | G.D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors |
| US6262277B1 (en) | 1994-09-13 | 2001-07-17 | G.D. Searle And Company | Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| AR008789A1 (es) | 1996-07-31 | 2000-02-23 | Bayer Corp | Piridinas y bifenilos substituidos |
| JP2894445B2 (ja) | 1997-02-12 | 1999-05-24 | 日本たばこ産業株式会社 | Ｃｅｔｐ活性阻害剤として有効な化合物 |
| DE19709125A1 (de) * | 1997-03-06 | 1998-09-10 | Bayer Ag | Substituierte Chinoline |
| AU3285499A (en) | 1998-02-13 | 1999-08-30 | G.D. Searle & Co. | Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity |
| JP4546589B2 (ja) * | 1998-04-23 | 2010-09-15 | 武田薬品工業株式会社 | ナフタレン誘導体 |
| DE69935992T4 (de) * | 1998-09-25 | 2008-05-29 | Monsanto Co., Chicago | Polycyclische aryl und heteroaryl substituierte tertiäre heteroalkylamine, für die hemmung der aktivität des cholesteryl-ester-transfer-proteins |
| EP1340509A1 (fr) | 1998-12-23 | 2003-09-03 | G.D. Searle LLC. | Combinaisons d'inhibiteurs de la protéine de transfert de l'ester de cholestéryle et de dérivés de l'acide fibrique utilisées dans le cadre de troubles cardio-vasculaires |
| HUP0104793A2 (en) | 1998-12-23 | 2002-06-29 | Searle Llc | Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications |
| MXPA01006470A (es) | 1998-12-23 | 2003-06-06 | Searle Llc | Combinaciones de inhibidores de transporte de acido biliar ileal y agentes de secuentro de acido biliar para indicaciones cardiovasculares. |
| ES2200587T3 (es) | 1998-12-23 | 2004-03-01 | G.D. Searle Llc | Combinaciones de inhibidors del transporte de acidos biliares del ileon e inhibidores de la proteina de transferencia de colesteril ester para indicaciones cardiovasculares. |
| AU3103800A (en) | 1998-12-23 | 2000-07-31 | G.D. Searle Llc | Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acidderivatives for cardiovascular indications |
| WO2000038722A1 (fr) | 1998-12-23 | 2000-07-06 | G.D. Searle & Co. | COMBINAISONS D'INHIBITEURS DE LA PROTEINE DE TRANSFERT DE L'ESTER DE CHOLESTERYLE ET D'INHIBITEURS DE LA HMG CoA-REDUCTASE UTILISEES DANS LE CADRE DE TROUBLES CARDIO-VASCULAIRES |
| WO2000038723A1 (fr) | 1998-12-23 | 2000-07-06 | G.D. Searle Llc | Combinaisons d'inhibiteurs de la proteine de transfert de l'ester de cholesteryle et d'agents sequestrants de l'acide biliaire, utilisees dans le cadre de toubles cardio-vasculaires |
| US6723752B2 (en) | 1999-09-23 | 2004-04-20 | Pharmacia Corporation | (R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| US6924313B1 (en) | 1999-09-23 | 2005-08-02 | Pfizer Inc. | Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| US20010018446A1 (en) | 1999-09-23 | 2001-08-30 | G.D. Searle & Co. | Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| EP1286984A2 (fr) | 2000-03-10 | 2003-03-05 | Pharmacia Corporation | Procede de preparation de tetrahydrobenzothiepines |
| US7115279B2 (en) | 2000-08-03 | 2006-10-03 | Curatolo William J | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| EP1269994A3 (fr) | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Compositions Pharmaceutiques comprenant un médicament et un polymère permettant d'améliorer la concentration du médicament |
| OA12625A (en) | 2001-06-22 | 2006-06-12 | Pfizer Prod Inc | Pharmaceutical compositions of adsorbates of amorphous drug. |
| ES2333645T3 (es) * | 2001-06-22 | 2010-02-25 | Bend Research, Inc. | Composiciones farmaceuticas de dispersiones de medicamentos y polimeros neutros. |
| EP2168576A3 (fr) * | 2001-09-14 | 2010-05-26 | Shionogi & Co., Ltd. | Composés tricycliques dans le traitement de la dyslipidémie et des maladies artériosclérotiques |
| WO2003040127A1 (fr) | 2001-11-02 | 2003-05-15 | G.D. Searle Llc | Composes benzothiepine mono- et di-fluores en tant qu'inhibiteurs du transport d'acides biliaires a co-dependance sodique apicale (asbt) et de reprise de taurocholate |
| CA2471639A1 (fr) | 2002-01-17 | 2003-07-31 | Pharmacia Corporation | Nouveaux composes d'alkyl/aryl hydroxy ou cetothiepine servant d'inhibiteurs du transport des acides biliaires de type ileal et de l'absorption de taurocholate |
| AR038375A1 (es) | 2002-02-01 | 2005-01-12 | Pfizer Prod Inc | Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo |
| EP1469832B2 (fr) | 2002-02-01 | 2016-10-26 | Bend Research, Inc. | Compositions pharmaceutiques de dispersions amorphes de medicaments et materiaux formant des microphases lipophiles |
| ES2310676T3 (es) | 2002-12-20 | 2009-01-16 | Pfizer Products Inc. | Formas de dosificacion que comprenden un inhibidor de cetp y un inhibidor de hmg-coa reductasa. |
| BRPI0408442A (pt) | 2003-03-17 | 2006-04-04 | Japan Tobacco Inc | método para aumento da biodisponibilidade oral de s-[2-([[1-(2-etilbutil)ciclohexil]carbonil]amino)fenil]2- metilpropanotioato |
| PL1603553T3 (pl) * | 2003-03-17 | 2012-04-30 | Japan Tobacco Inc | Kompozycje farmaceutyczne inhibitorów CETP |
| TWI494102B (zh) * | 2003-05-02 | 2015-08-01 | Japan Tobacco Inc | 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合 |
| CA2532931A1 (fr) * | 2003-08-04 | 2005-02-10 | Pfizer Products Inc. | Compositions pharmaceutiques a base d'adsorbats de medicaments amorphes et de produits aptes a former des microphases lipophiles |
| CL2004001884A1 (es) | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros. |
| EP1670446A2 (fr) * | 2003-09-26 | 2006-06-21 | Japan Tobacco Inc. | Procede pour inhiber la production de lipoproteines restantes |
| PE20050444A1 (es) * | 2003-10-31 | 2005-08-09 | Takeda Pharmaceutical | Compuestos de piridina como inhibidores de la peptidasa |
| FR2873368B1 (fr) | 2004-07-26 | 2008-01-04 | Merck Sante Soc Par Actions Si | Derives de guanidine et leurs utilisations en therapeutique |
| BRPI0519602A2 (pt) * | 2004-12-18 | 2009-02-25 | Bayer Healthcare Ag | derivados de tetrahidroquinolina substituÍdos com 4-cicloalquila e seu uso como medicamento |
| WO2006082518A1 (fr) | 2005-02-03 | 2006-08-10 | Pfizer Products Inc. | Compositions pharmaceutiques a efficacite amelioree |
| US7737155B2 (en) | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
| CA2625416A1 (fr) | 2005-10-21 | 2007-04-26 | Novartis Ag | Combinaison de composes organiques |
| EP1815919A1 (fr) * | 2006-02-03 | 2007-08-08 | Uponor Innovation Ab | Fabrication d'un produit allongé |
| DE102006012548A1 (de) * | 2006-03-18 | 2007-09-20 | Bayer Healthcare Ag | Substituierte Chromanol-Derivate und ihre Verwendung |
| US20110245209A1 (en) | 2008-12-16 | 2011-10-06 | Schering Corporation | Pyridopyrimidine derivatives and methods of use thereof |
| US20110243940A1 (en) | 2008-12-16 | 2011-10-06 | Schering Corporation | Bicyclic pyranone derivatives and methods of use thereof |
| CN102781937B (zh) * | 2009-12-21 | 2015-09-30 | 拜尔农作物科学股份公司 | 用作杀菌剂的双(二氟甲基)吡唑 |
| US8815775B2 (en) | 2010-05-18 | 2014-08-26 | Bayer Cropscience Ag | Bis(difluoromethyl)pyrazoles as fungicides |
| WO2012027331A1 (fr) | 2010-08-27 | 2012-03-01 | Ironwood Pharmaceuticals, Inc. | Compositions et procédés pour traiter ou prévenir un syndrome métabolique et des maladies et troubles associés |
| EP3180335B1 (fr) | 2014-08-11 | 2021-05-05 | Angion Biomedica Corporation | Inhibiteurs de cytochrome p450 et leurs utilisations |
| WO2016109492A1 (fr) | 2014-12-31 | 2016-07-07 | Angion Biomedica Corp | Méthodes et agents pour traiter une maladie |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5169857A (en) * | 1988-01-20 | 1992-12-08 | Bayer Aktiengesellschaft | 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis |
| GB8626344D0 (en) * | 1986-11-04 | 1986-12-03 | Zyma Sa | Bicyclic compounds |
| FI90236C (fi) * | 1987-07-10 | 1994-01-10 | Hoechst Ag | Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi |
| US4906624A (en) * | 1987-09-08 | 1990-03-06 | Warner-Lambert Company | 6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis |
| NO177005C (no) * | 1988-01-20 | 1995-07-05 | Bayer Ag | Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen |
| NZ230121A (en) * | 1988-08-29 | 1993-08-26 | Squibb & Sons Inc | Pyridine and quinoline terminal groups for hmg-coenzyme a reductase inhibitors and pharmaceutical compositions for lowering blood serum cholesterol levels |
| DE4244029A1 (de) * | 1992-12-24 | 1994-06-30 | Bayer Ag | Neue substituierte Pyridine |
-
1996
- 1996-03-20 DE DE19610932A patent/DE19610932A1/de not_active Withdrawn
-
1997
- 1997-02-25 HR HR19610932.9A patent/HRP970105A2/hr not_active Application Discontinuation
- 1997-03-07 AT AT97103813T patent/ATE194832T1/de not_active IP Right Cessation
- 1997-03-07 PT PT97103813T patent/PT796846E/pt unknown
- 1997-03-07 ES ES97103813T patent/ES2150157T3/es not_active Expired - Lifetime
- 1997-03-07 DE DE59702034T patent/DE59702034D1/de not_active Expired - Fee Related
- 1997-03-07 EP EP97103813A patent/EP0796846B1/fr not_active Expired - Lifetime
- 1997-03-07 DK DK97103813T patent/DK0796846T3/da active
- 1997-03-13 AU AU16280/97A patent/AU1628097A/en not_active Abandoned
- 1997-03-13 US US08/816,290 patent/US5925645A/en not_active Expired - Fee Related
- 1997-03-14 SG SG1997000783A patent/SG50805A1/en unknown
- 1997-03-17 NZ NZ314419A patent/NZ314419A/xx unknown
- 1997-03-17 IL IL12046897A patent/IL120468A0/xx unknown
- 1997-03-17 CA CA002200175A patent/CA2200175A1/fr not_active Abandoned
- 1997-03-17 JP JP9082454A patent/JPH09255574A/ja not_active Ceased
- 1997-03-18 TN TNTNSN97048A patent/TNSN97048A1/fr unknown
- 1997-03-18 BG BG101339A patent/BG101339A/xx unknown
- 1997-03-19 AR ARP970101096A patent/AR006318A1/es unknown
- 1997-03-19 PL PL97319050A patent/PL319050A1/xx unknown
- 1997-03-19 ZA ZA9702375A patent/ZA972375B/xx unknown
- 1997-03-19 SK SK361-97A patent/SK36197A3/sk unknown
- 1997-03-19 HU HU9700610A patent/HUP9700610A1/hu unknown
- 1997-03-19 CZ CZ97843A patent/CZ84397A3/cs unknown
- 1997-03-19 NO NO971269A patent/NO971269L/no unknown
- 1997-03-19 MY MYPI97001168A patent/MY132490A/en unknown
- 1997-03-19 BR BR9701348A patent/BR9701348A/pt not_active Application Discontinuation
- 1997-03-20 EE EE9700060A patent/EE9700060A/xx unknown
- 1997-03-20 CO CO97015054A patent/CO4520282A1/es unknown
- 1997-03-20 TR TR97/00213A patent/TR199700213A2/xx unknown
- 1997-03-20 ID IDP970913A patent/ID16292A/id unknown
-
1998
- 1998-12-21 US US09/217,214 patent/US6127383A/en not_active Expired - Fee Related
-
2000
- 2000-10-04 GR GR20000402236T patent/GR3034546T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT796846E (pt) | 2000-12-29 |
| ES2150157T3 (es) | 2000-11-16 |
| EP0796846B1 (fr) | 2000-07-19 |
| DK0796846T3 (da) | 2000-10-23 |
| GR3034546T3 (en) | 2001-01-31 |
| SG50805A1 (en) | 1998-07-20 |
| NO971269D0 (no) | 1997-03-19 |
| PL319050A1 (en) | 1997-09-29 |
| HUP9700610A1 (hu) | 2000-08-28 |
| MX9702042A (es) | 1997-09-30 |
| TR199700213A2 (xx) | 1997-10-21 |
| CZ84397A3 (en) | 1997-10-15 |
| NZ314419A (en) | 1998-12-23 |
| TNSN97048A1 (fr) | 2005-03-15 |
| US6127383A (en) | 2000-10-03 |
| EP0796846A1 (fr) | 1997-09-24 |
| HU9700610D0 (en) | 1997-05-28 |
| HRP970105A2 (en) | 1998-04-30 |
| CO4520282A1 (es) | 1997-10-15 |
| AU1628097A (en) | 1997-09-25 |
| MY132490A (en) | 2007-10-31 |
| BG101339A (en) | 1998-04-30 |
| US5925645A (en) | 1999-07-20 |
| DE59702034D1 (de) | 2000-08-24 |
| DE19610932A1 (de) | 1997-09-25 |
| AR006318A1 (es) | 1999-08-25 |
| ZA972375B (en) | 1997-09-25 |
| IL120468A0 (en) | 1997-07-13 |
| JPH09255574A (ja) | 1997-09-30 |
| EE9700060A (et) | 1997-10-15 |
| ATE194832T1 (de) | 2000-08-15 |
| BR9701348A (pt) | 1998-11-10 |
| CA2200175A1 (fr) | 1997-09-20 |
| SK36197A3 (en) | 1997-11-05 |
| ID16292A (id) | 1997-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO971269L (no) | 2-aryl-substituerte pyridiner | |
| ATE196140T1 (de) | Substituierte benzylaminoquinuclidine als substanz p antagonisten | |
| WO2003000679A3 (fr) | Pyridine substituee herbicide, son procede de fabrication et son utilisation comme herbicide et regulateur de croissance des plantes | |
| DE69840892D1 (de) | Pyrazolderivate, verfahren zu ihrer herstellung, zwischenprodukte und schädlingsbekämpfungsmittel, das diese als aktiven bestandteil enthält | |
| ATE114114T1 (de) | Verwendung von benzimidazol-derivaten als antibakterielle mittel. | |
| AU6703300A (en) | Fungicides | |
| CA2255620A1 (fr) | Nouveaux inhibiteurs d'anandamide amidase utiles en tant qu'agents analgesiques | |
| ATE235474T1 (de) | 4,1-benzoxazepinderivate als squalen-synthetase inhibitoren und ihre verwendung zur behandlung von hypercholesterämie und als fungizide | |
| MD960282A (en) | Herbicidal heterocyclic-substituted pyridines | |
| RU94036772A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования эндометриоза | |
| PT1023267E (pt) | Compostos de piridilo e composicoes farmaceuticas que os contem | |
| EP1184373A4 (fr) | Composes tricycliques | |
| AU8212591A (en) | Diphenylmethylpiperazine derivative | |
| ATE211474T1 (de) | Galanthamin derivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente | |
| DE69814800D1 (de) | Epoxysuccinamid-derivate oder ihre salze | |
| DK0696585T3 (da) | Nyt bisoxadiazolidinderivat | |
| HUP9901093A2 (hu) | Eljárás benzotiofénszármazékok felhasználása melanóma gátlására alkalmas gyógyszerkészítmények előállítására | |
| KR950701921A (ko) | 피리딘 화합물 및 이의 제약학적 용도(pyridine compound and medicinal use thereof) | |
| NO993738L (no) | 2-amino-substituerte pyridiner som kan anvendes ved behandling ved arteriosclerose og hyper-lipoproteinemi | |
| AU8460791A (en) | Compound, preparation and use | |
| NZ517315A (en) | New derivatives of A-500359 | |
| TW278024B (fr) | ||
| KR950007851A (ko) | 호산구 주화성 억제제 | |
| KR890011880A (ko) | 항궤양제 | |
| GR76984B (fr) |